幻覚剤であるN,N-ジメチルトリプタミン (DMT) は,内生シグマ-1受容体調節剤である
Dominique Fontanilla1, Molly Johannessen, Abdol R Hajipour
1Department of Pharmacology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA.
まとめ
N,N-ジメチルトリプタミン (DMT) は,神経系全体に存在するタンパク質であるシグマ-1受容体の内生性アゴニストです. この研究は,DMTがシグマ1受容体と結合し,ナトリウムチャネルとマウスの行動に影響することを示しています.
科学分野:
- 神経科学は神経科学である.
- 薬理学 薬理学とは
- 分子生物学は分子生物学である.
背景:
- シグマ1受容体は,中枢神経系と周辺部に広く分布するユニークなタンパク質です.
- 多くの合成化合物を結合するが,既知の内生性ペプチドリガンドがないため,孤児受容体として分類される.
- シグマ-1受容体の薬理学者は,主要標的が不明な既知の幻覚剤であるN,N-ジメチルトリプタミン (DMT) と構造的に類似している.
研究 の 目的:
- N,N-ジメチルトリプタミン (DMT) とシグマ-1受容体との相互作用を調査する.
- DMTがシグマ1受容体の内生性アゴニストとして作用するかどうかを判断する.
- シグマ-1受容体へのDMT結合の機能的影響を明らかにする.
主な方法:
- DMTがシグマ-1受容体と結合することを確認するための生化学分析.
- シグマ-1受容体を発現する原生心筋細胞および異種細胞における電圧ゲートされたナトリウムイオン (Na+) チャンネルの電気生理学的記録.
- DMTの生理学的効果を評価するために,野生型およびシグマ-1受容体ノックアウトマウスにおける行動研究.
主要な成果:
- DMTはシグマ1受容体と結合することを実証した.
- DMTは,シグマ-1受容体を発現する細胞の電圧誘導ナトリウムイオン (Na+) チャンネルを阻害した.
- DMTは,野生型のマウスでハイパーモビリティを誘発し,シグマ-1受容体ノックアウトマウスには効果がない.
結論:
- これらの発見は,N,N-ジメチルトリプタミン (DMT) がシグマ-1受容体の内生性アゴニストであることを強く示している.
- DMTとシグマ1受容体の相互作用は,イオンチャネル機能と動物の行動に影響を与える.
- この研究は,神経薬理学的な景観における重要な内生性リガンド受容体関係を明らかにしています.
関連する概念動画
CNS Stimulants: Psychedelic Agents
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
Hallucinogens and Psychedelics
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains delta-9-tetrahydrocannabinol (THC)...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains delta-9-tetrahydrocannabinol (THC)...
Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
The Pineal Gland
The pineal gland, a diminutive endocrine structure named for its pinecone-shaped appearance, is situated atop the third ventricle within the diencephalon region of the forebrain. This gland, composed of secretory cells known as pinealocytes arranged in compact cords and clusters around dense particles of calcium salts, plays a pivotal role in hormonal regulation.
The primary secretion of the pineal gland is the hormone melatonin, derived from serotonin. The concentration of melatonin in the...
The primary secretion of the pineal gland is the hormone melatonin, derived from serotonin. The concentration of melatonin in the...


